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Abstract
Background: Minor groove binding drugs (MGBDs) interact with DNA in a sequence-specific
manner and can cause changes in gene expression at the level of transcription. They serve as
valuable models for protein interactions with DNA and form an important class of antitumor,
antiviral, antitrypanosomal and antibacterial drugs. There is a need to extend knowledge of the
sequence requirements for MGBDs from in vitro DNA binding studies to living cells.
Results: Here we describe the use of microarray analysis to discover yeast genes that are affected
by treatment with the MGBD berenil, thereby allowing the investigation of its sequence
requirements for binding in vivo. A novel approach to sequence analysis allowed us to address
hypotheses about genes that were directly or indirectly affected by drug binding. The results show
that the sequence features of A/T richness and heteropolymeric character discovered by in vitro
berenil binding studies are found upstream of genes hypothesized to be directly affected by berenil
but not upstream of those hypothesized to be indirectly affected or those shown to be unaffected.
Conclusion: The data support the conclusion that effects of berenil on gene expression in yeast
cells can be explained by sequence patterns discovered by in vitro binding experiments. The results
shed light on the sequence and structural rules by which berenil binds to DNA and affects the
transcriptional regulation of genes and contribute generally to the development of MGBDs as tools
for basic and applied research.
Background
Improved understanding of the sequence rules by which
small molecules bind to DNA and alter patterns of gene
expression advances both basic and applied research. In
both of these contexts, molecules that bind noncovalently
in the DNA minor groove with sequence-selective recogni-
tion have drawn considerable attention [1]. Minor groove
binding drugs (MGBDs) have served as useful models for
protein components of the transcriptional machinery
since they can be more experimentally tractable than their
macromolecular counterparts. For example, the under-
standing of the mechanism of action of TATA box binding
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protein, a general transcription factor required for proper
initiation of transcription by RNA polymerase II, has been
furthered using the MGBDs distamycin A, Hoechst 33258,
and netropsin [2]. The observation that the MGBD berenil
affects mitochondrial function and aerobic respiration in
yeast suggests that it alters genome-wide patterns of gene
expression [3]. A long standing goal in drug development
has been the development of agents that can target spe-
cific genes in cells, altering patterns of gene expression in
a clinically relevant manner. Advances in the general areas
of synthetic organic chemistry, molecular biology and
biochemistry and specifically in genomics and functional
genomics have made the goal of developing more effec-
tive drugs tangible. MGBDs have attracted attention
because of their demonstrated antitumor, antiviral, anti-
bacterial, and antitrypanosomal activities [4-7]. For exam-
ple, brostallicin, a derivative of distamycin A, has been
shown to be cytotoxic to tumor cells [8] and underwent a
phase I clinical investigation involving patients with
advanced solid tumors [9]. MGBDs in the category of lex-
itropsins have been shown to have anticancer properties
as well; moderate cytotoxicity in human MCF-7 breast
cancer cells was exhibited by analogues of bis-netropsin
[10]. Berenil is a member of a family of MGBDs found to
be useful in the treatment of infectious diseases caused by
Pneumocystis jiroveci and trypanosomes [11], diseases of
concern in AIDS patients. The design of MGBDs as agents
that have more potency but fewer side effects relies on a
more thorough understanding of the ways in which
MGBDs effect changes at the level of transcription by
interacting with promoter DNA and transcription factors
of specific genes in the context of chromatin.
MGBDs have cationic charges, narrow molecular cross
section, and concave shape, allowing them to fit into the
narrow minor groove of DNA [1]. MGBD binding
depends on the spine of hydration, van der Waal's interac-
tions with the floor or walls of the minor groove, charge
interactions between cationic drug groups and negative
electrostatic sequences, the shapes of base pairs, and the
width of the minor groove. Because these features vary in
a sequence dependent manner, MGBDs exhibit sequence
selectivity properties that have been subject of intense
study using in vitro binding to oligonucleotides and poly-
meric DNA. MGBDs have been shown to exhibit a prefer-
ence for short tracts of A/T-rich sequences [12]. The length
of DNA protected by MGBDs varies from 4 to 6 bp [13].
The sequence specificity of the MGBD berenil was investi-
gated by measurement of its binding affinity to hairpin
oligonucleotides containing all 512 possible 5-mer
sequences [14]. The results showed that of 512 sequences
studied, all the sequences that were entirely A+T ranked
among the fifty best binding sequences, supporting the
conclusion that berenil prefers A/T-rich binding sites.
Berenil is also apparently able to discriminate among
sequences composed only of A+T. The two most optimal
binding sequences found in Boger et al. were ATATT and
AATAT. Binding of berenil to sequences of the form
GGGG(A/T)4GGGG was studied using electrospray ioni-
zation mass spectrometry and it was found to bind
sequences in the order ATAT > AATT > AAAA [15]. DNase
I footprinting studies revealed the binding of berenil to
ATAT, AATT, TAAT, TTAA, and TATA [13]. Rotational vis-
cometry measurements found the sites of highest berenil
binding strength to be alternating helical A/T segments
[16]. An overarching conclusion from these studies is that
berenil prefers to bind to A/T-rich sequences that are het-
eropolymeric, with A and T alternating on the same
strand.
There is a need to extend the study of the sequence
requirements for MGBDs to the context of living cells. We
chose to contribute to this effort by investigating the
effects of the berenil on yeast gene expression, enabling an
examination of its in vivo sequence binding requirements.
Our experimental data and analysis promise to contribute
to the body of knowledge of MGBDs with basic and
applied research applications.
Results and Discussion
Measuring effects of berenil on yeast mRNA levels
The approach we took to finding putative in vivo binding
sites for berenil was to consider the yeast genome as a
bank of DNA sequences that, in the context of chromatin
and the environment of the nucleus, have various affini-
ties for the drug. Among these are sequences whose role in
the regulation of transcription could be affected by berenil
binding. Changes in gene expression at the level of tran-
scription could therefore occur directly through mecha-
nisms such as interfering with transcription factor binding
or altering chromatin structure [2,17]. Indirect effects on
transcript levels may also occur through gene regulatory
networks or general stress response [18]. We sought to use
microarray analysis to determine the set of yeast genes
that are directly or indirectly affected at the level of tran-
scription by berenil. We then addressed the significant
challenge of distinguishing between these two categories
during analysis of the upstream regions of affected genes.
Generation of an affected gene list
Our experimental method was to culture yeast in the pres-
ence and absence of berenil, isolate total RNA, and con-
duct microarray hybridizations to measure changes in
steady state transcript levels for all yeast genes. We gath-
ered data suitable for analysis from five experiments, with
two whole-genome microarrays in each experiment and
two of them conducted as dye swaps of the other three.
We analyzed microarray data using MicroArray Genome
Imaging and Clustering (MAGIC) Tool [19]. Once MAGIC
Tool produced files of foreground and background inten-BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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sities for all of the microarray experiments, we used Excel
to analyze the data. Differences in the performance of the
two dyes were accounted for by normalization [20]. A
series of filtering criteria were used to ensure that only reli-
able data were used in the production of an affected gene
list. As described in the Methods section, the criteria for
inclusion of the data for a given ORF were 1) the sum of
the intensities for the two channels had to be greater than
the minimum median of that sum for all the experiments,
2) the foreground for at least one channel had to be dou-
ble the background, 3) data for a feature had to pass the
first two filters in at least 5 of the 10 measurements of that
feature, 4) data for a feature must pass the first two filters
in both Cy3- and Cy5-labelled samples, and 5) the coeffi-
cient of variation of log transformed ratios across experi-
ments had to be less than one. The culmination of our
analysis was a list of ORFs for which we had reliable
microarray data. This resulted in a final list of 52 genes
whose mRNA levels decreased and two whose levels
increased upon berenil treatment. We find it very interest-
ing that the vast majority of the reliably affected genes
were negatively affected; this observation is likely to be
relevant to discovery of the mechanism of action of bere-
nil and other MGBDs.
Real time PCR validation of microarray results
In order to provide validation of the microarray results
from an independent method, we performed real time
PCR measurements for selected genes. Quantitative
reverse transcription real time PCR with SYBR Green
reporting was used to generate the data presented in Table
1. The gene TUB1 was used as a standard as described [21]
and was also unaffected in our microarray experiments.
The genes STF2, HSP78, and SPI1 were found to have
lower steady state levels of mRNA according to the micro-
array data and also had lower levels according to real time
PCR. Although the genes appeared in the same order with
regard to the magnitude of the effect, the real time data
resulted in higher expression ratios, an effect that may be
due to signal saturation in the microarray experimental
approach.
Direct and indirect effects of berenil
The list of genes whose steady state transcript levels were
shown by our microarray analysis to be reliably affected
by berenil includes two genes whose levels increased.
According to the Saccharomyces Genome Database
(SGD), their functions are in phosphate metabolism and
processing of 20S pre-RNA [22]. Of the 52 genes whose
mRNA levels decrease, 14 are involved in stress response,
nine in carbohydrate metabolism, four in electron trans-
port, two in meiosis and mitosis, one in regulation of
redox homeostasis, one in regulation of proteolysis, one
in salinity response, one in vacuole fusion, one in
response to metals, one in phosphate metabolism, and
one in DNA repair, according to the SGD. The remaining
16 genes have not had functions assigned to them by
SGD. The list of affected genes is likely to include some
that are directly affected by berenil. Genes in this category
are expected to have upstream transcriptional control
regions that include berenil binding sites. Genes whose
transcript levels changed by indirect drug effects are also
likely to be in the list. Such genes would not be expected
to contain berenil binding sites in their upstream control
regions. Although we cannot determine which genes may
be indirectly affected through gene regulatory networks,
we note that there are a number of genes that function in
stress response. We chose to test the hypothesis that these
14 genes are indirectly affected by berenil and that the
remaining genes are directly affected. Table 2 lists the 40
genes hypothesized to be directly affected while Table 3
lists those hypothesized to be indirectly affected, each
with an expression ratio, function, and molecular process,
if known.
Sequences found upstream of affected genes
We sought to analyze the upstream regions of the hypoth-
esized direct and indirect categories of genes for the occur-
rence of sequence features and to consider the results in
light of in vitro berenil binding studies. In this way, we can
address the validity of our categorization of the affected
genes and extend knowledge of berenil binding prefer-
ences to the environment of cells. As reviewed above,
studies conducted in vitro have shown that berenil binds
5–6 nucleotide A/T-rich tracts that tend toward heteropol-
ymeric (alternating A and T) character [13-16]. If these
binding preferences extend to the cellular context, then
the upstream sequences of the 40 yeast genes hypothe-
sized to be directly affected by berenil and listed in Table
2 are expected to contain 5–6 nucleotide sequence ele-
Table 1: Validation of microarray data with real time PCR
Gene Microarray Real Time PCR
TUB1 -0.11 0.00 (standard)
STF2 -1.14 -1.81
HSP78 -1.42 -2.60
SPI1 -1.51 -2.74
Expression ratios (log2 transformed treated to untreated) of mRNA levels for selected genes inferred from microarray analysis versus real time 
PCR.BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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ments that are A/T-rich and heteropolymeric. For the 14
genes hypothesized to be indirectly affected and listed in
Table 3, the signal of berenil binding sequences should
fall to the background level found in the upstream
sequences of all yeast genes. Our challenge was to find
ways to analyze the sequences in order to uncover any
Table 2: Direct hypothesis category of yeast genes shown by microarray analysis to be affected by berenil treatment
ORF Gene Ratio Function Process
YBR233W-A DAD3 -3.45 mitosis protein binding activity
Q0130 OLI1 -2.75 ATP synthase activity ATP synthesis coupled 
proton transport
YDR070C FMP16 -2.43 unknown unknown
YEL039C CYC7 -2.41 electron transport electron carrier activity
YLR327C TMA10 -2.35 unknown unknown
YJL156W-A YJL156W-A -2.25 unknown unknown
YMR105C PGM2 -2.23 glucose 1-phosphate 
utilization
phosphoglucomutase 
activity
YGR248W SOL4 -2.00 unknown unknown
YHR087W YHR087W -1.95 unknown unknown
YPR160W GPH1 -1.76 glycogen catabolism glycogen phosphorylase 
activity
YLR178C TFS1 -1.76 regulation of proteolysis lipid binding activity
YOR173W DCS2 -1.72 unknown unknown
YEL011W GLC3 -1.66 glycogen metabolism 1,4-alpha-glucan branching 
enzyme activity
YMR081C ISF1 -1.64 aerobic respiration unknown
YER150W SPI1 -1.51 unknown unknown
YER067W YER067W -1.50 unknown unknown
YOR031W CRS5 -1.45 response to metal ion copper ion binding activity
YIL136W OM45 -1.43 unknown unknown
YPL230W YPL230W -1.41 unknown unknown
YOR178C GAC1 -1.38 meiosis protein phosphatase type 1 
activity
YFR053C HXK1 -1.35 fructose metabolism hexokinase activity
YOR120W GCY1 -1.33 salinity response aldo-keto reductase 
activity
YFR017C YFR017C -1.32 unknown unknown
YOR374W ALD4 -1.31 ethanol metabolism aldehyde dehydrogenase 
(NAD+) activity
YJR096W YJR096W -1.29 arabinose metabolism oxidoreductase activity
YFR015C GSY1 -1.27 glycogen metabolism glycogen (starch) synthase 
activity
YDR453C TSA2 -1.22 regulation of redox 
homeostasis
thioredoxin peroxidase 
activity
YHL021C FMP12 -1.21 unknown unknown
YKL151C YKL151C -1.15 unknown unknown
YGR008C STF2 -1.14 ATP synthesis unknown
YDL130W-A STF1 -1.09 ATP synthesis unknown
YCL042W YCL042W -1.08 unknown unknown
YOR385W YOR385W -1.07 unknown unknown
YIL045W PIG2 -1.07 unknown protein phosphatase 
regulator activity
YLR258W GSY2 -1.06 glycogen metabolism glycogen (starch) synthase 
activity
YMR173W DDR48 -1.04 DNA repair unknown
YNL015W PBI2 -1.03 vacuole fusion (non-
autophagic)
endopeptidase inhibitor 
activity
YCL040W GLK1 -1.02 carbohydrate metabolism glucokinase activity
YAR071W PHO11 1.02 phosphate metabolism acid phosphatase activity
YKL099C UTP11 1.18 processing of 20S pre-
rRNA
snoRNA binding activity
Genes hypothesized to be directly affected by berenil treatment are listed with their expression ratios (log2 transformed treated to untreated) and 
functions, if known.BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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existing sequence patterns. We reasoned that if the effect
of berenil on transcription levels is due to binding sites
that they would be found upstream of directly affected
genes as 5-mer and 6-mer sequences. In order to reduce
the background noise, we limited our search to 200 nt
upstream of the start site for translation and to the sense
strand only. We developed two measures for determining
whether the occurrence rate of a given sequence element
is unusually high in the upstream regions of genes. The
first was the difference between the percentages of the
upstream regions of affected and unaffected genes con-
taining a sequence. The second is the ratio of the number
of occurrences of a sequence in the affected gene upstream
regions to that of the unaffected gene upstream regions.
For use as a control group, we assembled a list of 56 genes
that remained reliably unaffected by berenil treatment in
the course of our microarray experiments. Sense strand
sequences from the 200 bp upstream of these genes, the
40 directly affected genes, and the 14 indirectly affected
genes were measured for the occurrence of all possible 5-
mer and 6-mer sequences The percentage of genes with
an. occurrence of each sequence was determined for each
of the three categories and the difference in percentage
was calculated between each of the two affected categories
and the unaffected category.
Table 4 shows the top ten 5-mer and 6-mer sequences
from the direct category according to this criterion. For
example, AATAA occurred upstream of 71% of the directly
Table 3: Indirect hypothesis category of yeast genes shown by microarray analysis to be affected by berenil treatment
ORF Gene Ratio Function Process
YOL052C-A DDR2 -2.44 response to stress unknown
YGR088W CTT1 -2.35 response to stress catalase activity
YBR072W HSP26 -2.32 response to stress chaperone activity
YML100W TSL1 -2.17 response to stress enzyme regulator activity
YCR021C HSP30 -2.17 response to stress heat shock protein activity
YFL014W HSP12 -1.93 response to oxidative 
stress
heat shock protein activity
YMR250W GAD1 -1.66 response to oxidative 
stress
glutamate decarboxylase
YMR169C ALD3 -1.64 response to stress aldehyde dehydrogenase
YNL160W YGP1 -1.42 response to stress unknown
YDR258C HSP78 -1.42 response to stress chaperone activity
YDR074W TPS2 -1.28 response to stress trehalose phosphatase
YKL026C GPX1 -1.24 response to oxidative 
stress
glutathione peroxidase
YLL026W HSP104 -1.18 response to stress heat shock protein activity
YLL039C UBI4 -1.18 response to stress protein tagging activity
Genes hypothesized to be indirectly affected by berenil treatment are listed with their expression ratios (log2 transformed treated to untreated) 
and functions, if known.
Table 4: Difference criterion sequences in direct gene category
5-mer Directly Affected Difference 6-mer Directly Affected Difference
aataa 71% 31% tatata 61% 33%
ataag 58 29 atataa 58 32
agaat 50 25 aaaaga 45 23
aacaa 55 24 aaataa 45 21
aaata 74 23 aaaata 37 20
atata 74 23 tataag 34 20
tataa 74 23 taataa 32 19
cataa 42 22 gaaata 29 18
gtaaa 47 22 aaagaa 47 16
aaaga 66 19 aataat 29 16
Sequences found to be most overrepresented in the upstream regions of genes hypothesized to be directly affected by berenil compared to 
unaffected genes. The percentage of affected genes and difference in percentage between affected and unaffected genes having each sequence is 
listed. Bolded sequences are shared with Table 5.BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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affected genes, but in only 40% of the unaffected ones, for
a difference of 31%. The sequences listed occur in an aver-
age of 61% of the direct gene upstream regions. All of
them occur more frequently upstream of direct category
genes than of the unaffected genes; the average occurrence
is 23% higher. We also measured the number of occur-
rences of each sequence in the directly affected, indirectly
affected, and unaffected gene upstream regions. The ratio
of the number of occurrences in the affected category to
that in the unaffected one was calculated and the
sequences were ranked according to this ratio, with the
top ten sequences listed in Table 5. For example, the
sequence ATAAG occurs in 30 times in the 40 affected
gene upstream regions, a rate that is 2.3 times higher than
in the unaffected gene regions. The sequences listed occur
an average of 28 times in the 40 directly affected genes, an
average of 2.1 times the occurrence rate found in the 56
unaffected gene regions.
Table 6 shows the top ten sequences according to the dif-
ference criterion for the indirect gene category. For exam-
ple, ACCTC occurs in 50% of the indirect gene regions but
only 2% of the unaffected one, for a difference of 48%.
The sequences listed occur in an average of 50% of the 14
genes hypothesized to be indirectly affected with an aver-
age difference of 35% between the affected and unaffected
gene regions. Table 7 shows the results of ranking
sequences in the upstream region of genes in the indirect
category using the ratio criterion. For example, the
sequence AATCT occurs nine times in the indirect
sequence regions, a rate that is 3.3 times higher than that
found for the unaffected genes. The sequences listed occur
an average of 7.8 times in the upstream regions of the 14
indirectly affected gene set, an average of 4.4 times higher
than the rate found for the 56 unaffected genes.
The difference and ratio criteria for choosing overrepre-
sented sequences yield more similar results for the direct
category than for the indirect category. Of the 20
sequences from the direct category listed in Table 4, 15 are
found in Table 5, shown in bold. Only nine indirect cate-
gory sequences are shared between Tables 6 and 7. The
extent to which the difference and ratio lists share
sequences can be attributed to three causes. First, the two
measures are not unrelated. The number of occurrences of
a given sequence affects the number of genes with which
it is associated, and vice versa. Second, an average of one
shared sequence is expected at random. Third, shared
sequences may occur because they reflect sequence char-
acteristics of the data set. Since the first two of these causes
are not expected to be different for the direct and indirect
categories, the increased level of shared sequences for the
direct category is telling. It is likely to arise from character-
istics of the upstream regions of the direct category genes.
In order to investigate these characteristics, we formed sets
of unique 5- and 6-mers for the direct and indirect catego-
ries that included each shared sequence only once and
conducted several types of sequence analysis.
Sequence analysis
Several observations can be made regarding the sequences
presented in Tables 4, 5, 6, 7 that can be used to address
our hypotheses about genes that are directly or indirectly
affected by berenil and to evaluate the extent to which the
rules for drug binding in vitro can be extended to the cel-
lular context. These observations relate to the A+T content
and the extent of heteropolymeric character found in the
sequences listed in Tables 4, 5, 6, 7 and are outlined in the
following sections.
1. Overall A/T Richness in Direct Category Sequences
The most obvious characteristic of the 5- and 6-mer
sequences found to be overrepresented upstream of the
direct category genes is A/T richness. The set of unique 5-
mers listed for the direct category in Tables 4 and 5 is 89%
A+T while the unique 6-mers listed are 94% A+T. For com-
parison, the A+T content of the 200 nt upstream regions
of 5869 yeast genes averages 65%. The results of a Z-test
Table 5: Ratio criterion sequences in direct gene category
5-mer Directly Affected Ratio 6-mer Directly Affected Ratio
ataag 30 2.3 tataag 15 2.6
aacaa 36 2.1 atataa 28 2.6
aataa 48 2.1 aatata 19 2.4
gtaaa 25 2.1 gaaata 12 2.4
taata 33 1.8 taataa 15 2.3
acata 25 1.8 tatata 35 2.2
agaat 24 1.8 aataat 14 2.2
atata 56 1.7 aaataa 22 2.1
tataa 42 1.7 ataata 16 2.0
tatat 48 1.5 aaaaga 20 2.0
Sequences ranked according to the number of occurrence in upstream regions of genes hypothesized to be directly affected compared to 
unaffected genes. The number of occurrences in affected genes and ratio of occurrences in affected genes to unaffected genes is listed for each 
sequence. Bolded sequences are shared with Table 4.BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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showed a high level of significance (p < .0001) for the A+T
content of both the 5- and 6-mers compared to the set of
all yeast genes. The 5- and 6-mer sequences from the indi-
rect category in Tables 6 and 7 average 72% and 73% A+T,
respectively. These values are not significantly different
from all yeast genes, with p-values of 0.19 and 0.14. These
observations support the conclusion that A/T richness is a
characteristic of the direct category sequences much more
than it is of the indirect category sequences.
2. A/T Richness of Individual Direct Category Sequences
Another observation is that the A+T content levels of indi-
vidual members of the direct category lists are uniformly
high. In Tables 4 and 5, 100% of the 5- and 6-mers are at
least 80% A+T. The average value of this measure for 5869
yeast genes upstream regions is only 35% and 19% for 5-
mers and 6-mers, respectively. By contrast, of the indirect
category sequences of Tables 6 and 7, only 65% of the 17
unique 5-mers and 43% of the 14 unique 6-mers are at
least 80% A+T. The high A+T content of individual 5- and
6-mers from the direct category means that none of them
contains more than one C or G nucleotide. Interestingly,
each time a C or G occurs, it is either at the end of the
sequence or it disrupts a 2–5 nt homopolymeric A stretch.
3. High Rate of AT and TA Dinucleotides in Direct Category
The occurrence of heteropolymeric AT and TA dinucle-
otides is unusually high in the direct category compared to
the indirect category. Among the 25 unique 5- and 6-mers
in Tables 4 and 5 from the direct category, 52% of the
dinucleotides are AT and TA. Based on the number of As
and Ts in the sequences, a level of 33% is expected by
chance. Of the dinucleotides in the 31 unique indirect cat-
egory sequences of Tables 6 and 7, 25% are AT and TA,
while 23% are expected by the number of As and Ts. For
the analogous region upstream of 5869 yeast genes, 18%
of dinucleotides are AT or TA, with an expected value of
21% based on As and Ts.
4. Occurrence of Completely Heteropolymeric A/T Sequences
The completely A/T heteropolymeric sequences ATATA,
TATAT, ATATAT, and TATATA occur at high rates in the
direct category. Of eight possible sequences that are 100%
alternating As and Ts that could have occurred in Tables 4
Table 6: Difference criterion sequences in indirect gene category
5-mer Indirectly Affected Difference 6-mer Indirectly Affected Difference
acctc 50% 48% ctgaaa 42% 38%
aatct 58 42 taagga 42 38
ctaat 58 40 atataa 58 33
ctcac 50 37 aaacaa 50 32
cttat 50 37 aaacca 42 31
gatta 50 37 aataca 42 31
aacaa 67 36 tctttc 42 31
ataca 67 36 ataaat 50 30
aaagc 50 35 acacat 33 30
acaca 58 35 ctcacc 33 30
Sequences found to be most overrepresented in the upstream regions of genes hypothesized to be indirectly affected by berenil compared to 
unaffected genes. The percentage of affected genes and difference in percentage between affected and unaffected genes having each sequence is 
listed. Bolded sequences are shared with Table 7.
Table 7: Ratio criterion sequences in indirect gene category
5-mer Indirectly Affected Ratio 6-mer Indirectly Affected Ratio
aatct 9 3.3 cattct 5 20.0
aacaa 16 2.7 ctgaaa 51 0 . 0
caaca 8 2.5 taagga 51 0 . 0
caata 8 2.3 aacaac 5 5.0
aatac 8 2.1 acaaca 5 5.0
tctct 9 2.1 tataag 7 3.5
acaca 82 . 0 aaacca 53 . 3
tataa 17 2.0 aataca 53 . 3
ataag 8 1.8 tctttc 53 . 3
gaata 9 1.6 aaacaa 93 . 0
Sequences ranked according to the number of occurrence in upstream regions of genes hypothesized to be indirectly affected compared to 
unaffected genes. The number of occurrences in affected genes and ratio of occurrences in affected genes to unaffected genes is listed for each 
sequence. Bolded sequences are shared with Table 6.BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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and 5, five appear. Based on A+T content, only 1.1 occur-
rences would be expected at random. By contrast, none of
these sequences occurs in the indirect category lists of
Tables 6 and 7. This observation is best explained by lower
A+T content; an average of 0.34 occurrences would be
expected based on A+T content.
5. Direct Category Sequences Enriched for Heteropolymeric A/T 
Tracts
There is a high rate of occurrence of 2–6 nt heteropoly-
meric A/T tracts among the set of unique 5- and 6-mers
from the direct gene category. In order to investigate sta-
tistical significance of this observation, we compared the
rate of occurrence of heteropolymeric A/T tracts for both
the direct and indirect category to that found in the 200 nt
upstream regions of 5869 yeast genes, and the results are
listed in Table 8. Heteropolymeric tracts of 2–5 nt in
length occur an average of 7.9 times more often in the
unique direct category 5-mers than in the set of 5869 yeast
genes and 8.6 times more often in the unique direct cate-
gory 6-mers. Among the unique indirect category 5- and 6-
mers, the heteropolymeric tracts occur at average rates of
only 1.3 and 1.9 times higher than in the 5869 yeast
genes. We also conducted a one-sided Z-test of the rates of
occurrence of the heteropolymeric A/T tracts in both the
direct and indirect categories compared to the set of all
yeast genes. Although the significance levels are inflated
by the lack of independence in overlapping heteropoly-
meric A/T tracts, this affects both the direct and indirect
categories equally, so the resulting p-values can be fairly
compared. As shown in Table 8, p-values of less than
0.0001 indicate very high levels of statistical significance
for each of the nine direct category comparisons. These
results indicate that heteropolymeric A/T tracts of 2–6 nt
occur at a higher rate in the direct category sequences
compared to yeast genes in general. Enrichment of heter-
opolymeric A/T tracts in the indirect category compared to
the 5869 yeast genes is far less significant, and the signifi-
cance levels decrease as the tract length increases.
6. Basis for Heteropolymeric A/T Tracts
Clearly, the occurrence of heteropolymeric A/T tracts is
higher in the upstream regions of the direct category genes
than in the corresponding regions of the indirect category
genes or of yeast genes in general. But to what extent can
this be attributed to the A/T richness of these regions or to
the high rate of occurrence of A/T tracts of any type? We
sought to address these questions by conducting an anal-
ysis of the rate of occurrence of heteropolymeric
sequences compared to the rate expected by either A+T
content or the occurrence of 100% A/T tracts. We first tab-
ulated the number of occurrences of 3–6 nt A/T heteropol-
ymeric tracts in each of the eight lists of Tables 4, 5, 6, 7.
We then used two different means to establish an expected
Table 8: Analysis of A/T heteropolymeric sequence occurrences
A/T 
Heteropolymeric 
Sequences
5-mers 6-mers
Direct Indirect Direct Indirect
AT, TA observed 0.500 0.294 0.533 0.214
yeast 0.180 0.180 0.180 0.180
p-value < .0001 0.007 < .0001 0.228
ATA, TAT observed 0.359 0.157 0.396 0.125
yeast 0.065 0.065 0.065 0.065
p-value < .0001 0.004 < .0001 0.033
ATAT, TATA observed 0.192 0.029 0.222 0.071
yeast 0.024 0.024 0.024 0.024
p-value < .0001 0.418 < .0001 0.022
ATATA, TATAT observed 0.154 0.000 0.167 0.036
yeast 0.010 0.010 0.010 0.010
p-value < .0001 0.662 < .0001 0.090
ATATAT, 
TATATA
observed - - 0.083 0.000
yeast - - 0.010 0.010
p-value - - < .0001 0.579
The rate of occurrence (observed) of 2–6 nt A/T heteropolymeric sequences in the unique 5-mer and 6-mer sequences listed in Tables 4-7 for the 
direct and indirect gene categories was compared to the rate of occurrence (yeast) in the 200 nt upstream region of 5869 yeast genes using a 1-
sided Z-test. Highly significant p-values are shown in bold.BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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number of occurrences of these sequences. One was sim-
ply A+T content, with the consequence that higher con-
tent results in more expected occurrences of the A/T
heteropolymeric tracts. The other involved using the
number of 100% A/T tracts that occurs in a given list to
determine the expected number of A/T heteropolymeric
tracts. For 3 nt A/T tracts, two out of eight are expected at
random to be ATA or TAT. For 4 nt tracts, the expected rate
is two of 16, for 5 nt two of 32, and for 6 nt two of 64. For
the direct sequences listed in Table 4, A/T heteropolymeric
tracts of all sizes occur at rates greater than expected by
A+T content, with an average ratio of observed to expected
of 3.3. The same is true for the direct category sequences
in Table 5, with an average ratio of 4.2. However, A/T het-
eropolymeric tracts in the sequences from the indirect lists
in Tables 6 and 7 occur near the expected frequencies,
with ratios of observed to expected of 1.8 and 0.6, respec-
tively. Using the expected values from the occurrence of
100% A+T tracts, the sequences of Tables 4 and 5 still dis-
play unusually high occurrences of A/T heteropolymeric
tracts, with ratios of observed to expected of 3.0 and 3.6,
respectively. However, the indirect sequence category has
the expected sequence properties since the ratio of
observed to expected for Table 6 is 1.2 and the ratio for
Table 7 is 0.8. We also conducted a Chi-squared analysis
of the occurrence of 3–6 nt A/T heteropolymeric
sequences in each of the lists from Tables 4, 5, 6, 7. Strik-
ingly, for the unique direct category sequences there is
high degree of statistical significance for the occurrence of
A/T heteropolymeric tracts based on A+T content in every
one of the seven combinations of tract length and 5-mer
versus 6-mer (p-values range from < .0001 to .018). All
seven direct category combinations also yielded a high
degree of significance when the expected values were
based on A/T tracts (p-values from < .0001 to .013).
Equally striking is the result that for the unique indirect
category sequences, none of the fourteen analyses showed
statistical significance (p-values from .13 to .89), indicat-
ing that A/T heteropolymeric tracts occur at expected fre-
quencies.
Conclusion
The results of our microarray experiments and associated
sequence analysis provide insight into the sequence pat-
terns required for binding of the minor groove binder
berenil in the environment of yeast cells. They support the
conclusion that the upstream regions of the genes hypoth-
esized to be directly affected by berenil contain sequence
features that are in good accord with those discovered by
in vitro berenil binding studies. This was established by
observation of sequence characteristics of the upstream
regions of the direct category genes: high A+T content, A/
T richness of the most frequently found 5- and 6-mers,
and a high rate of occurrence of 2–6 nt heteropolymeric
A/T sequences. By contrast, these sequence features were
not apparent in the upstream regions of the genes hypoth-
esized to be indirectly affected by berenil or by those
shown to be unaffected by the treatment.
Our hypotheses about which genes were directly affected
by berenil and which were indirectly affected were based
solely on information about their functions. However,
each of the ways that we analyzed the sequences found
upstream of the genes supported the conclusion that the
direct category upstream regions contained sequence
characteristics found by in vitro binding studies while the
indirect category regions did not. These hypotheses would
benefit from further experimentation on individual genes
and on the mechanism by which direct and indirect effects
are manifested.
Our observation that 52 of the 54 affected yeast genes
were negatively affected by berenil may have important
implications for the mechanism of action of the drug,
directing us to several possible mechanisms of drug bind-
ing that can be expressed as testable hypotheses. One
hypothesis is that the drug interferes with the binding of
transcription factors to DNA upstream of affected genes.
This hypothesis is supported by several studies. For exam-
ple, MGBDs have been shown to compete with the tran-
scription factor NF-Y for binding to the DNA minor
groove [23] and to both prevent and disrupt binding of
TBP to it [24]. Of the 25 unique sequences listed in Tables
4 and 5 from the upstream regions of the direct category
genes, five are exact matches to the TBP consensus binding
site of TATAWAW [25]. There are also three matches to the
TBP consensus among the indirect category sequences of
Tables 6 and 7. TBP was found to bind the TATA box
sequence TATATAAA from the yeast CYC1 gene [26].
Seven exact matches to this sequence are found of all four
direct category lists while only two are found in the indi-
rect lists. HAP1 is a zinc finger transcription factor of the
Zn(2)-Cys(6) binuclear cluster domain type that is known
to make minor groove contact with the sequence
GCTAATAGCGATAATAGCGAGGG [27]. This sequence
includes two exact matches to the unique direct sequences
listed in Tables 4 and 5 and only one match to the unique
indirect sequences in Tables 6 and 7. It is also found in the
upstream region of CYC7, a gene whose expression level
was found to be lowered by berenil in our study.
A second hypothesis is that berenil is able to affect the ini-
tiation of transcription by altering the conformation of
DNA in promoter sequences. Evidence points to the abil-
ity of MGBDs to bind to the narrowed minor groove of A/
T tracts spaced at a periodicity that produces intrinsic
DNA curvature; uncurving of naked DNA by MGBDs has
also been demonstrated [28]. In order to make predic-
tions of DNA curvature for the upstream regions of our
affected genes, we used bend.it ® [29] to calculate pre-BMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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dicted curvature in 500 bp regions upstream of the 54
genes shown by our study to be affected by berenil [30].
Regions of strongly predicted curvature were notably
absent; the maximum was 2.4 degrees/helical turn and the
average value was 2.2 degrees/helical turn whereas DNA
sequences shown experimentally to demonstrate curva-
ture give values between 10 and 20 degrees/helical turn
[30]. Although these observations do not support the
hypothesis that berenil affects the regulation of transcrip-
tion by uncurving DNA, the possibility remains that it
introduces DNA curvature.
A third hypothesis is that MGBDs cause changes in chro-
matin structure indirectly through effects on DNA curva-
ture. Curved DNA has been shown to position
nucleosomes in reconstitution studies, to affect the stabil-
ity of nucleosomes, and to disrupt nucleosomes assem-
bled onto curved DNA [17,31]. Perhaps berenil negatively
influences transcription by preventing upstream
sequences from interacting with nucleosomes and posi-
tively affects transcription by facilitating the interaction of
upstream sequences with nucleosomes. A testable model
is that a nucleosome is positioned at upstream sequences
in a way that allows access at adjacent downstream linker
regions for transcription factors. For a gene that is
expressed, the upstream sequence would position the
nucleosome. Binding of berenil could alter the DNA cur-
vature in a way that would prevent the nucleosome posi-
tioning and reduce access by the transcription factor.
Conversely, a gene that is not as active in transcription
may have a sequence that, when bound by berenil, adopts
a conformation that attracts a positioned nucleosome and
makes a transcription factor binding site available, up-reg-
ulating transcription. Perhaps the former of these two
mechanisms occurs more readily, since the vast majority
of the affected genes in our study were negatively affected
by berenil.
Clearly, much more can be learned about the mechanism
by which berenil and other MGBDs affect gene expression
at the level of transcription. However, the results reported
here provide an extension from in vitro binding studies to
experiments involving cells. Extension of this work prom-
ises to contribute to the further development of MGBDs as
tools for basic research and drugs with important clinical
applications.
Methods
Yeast culture and RNA isolation
Yeast were inoculated at a level of A660 = 0.2 and cultured
at 30C for four hours in the presence and absence of 10
μM berenil. The incubation time was chosen in order to
expose the yeast to berenil for two generations and the
concentration was that required for a measurable effect of
berenil on yeast colony size (data not shown). However,
no effect on growth as measurable by A660 was observed
over the course of the treatment. Total RNA was isolated
from the two yeast cultures using the Ambion Ribopure
Yeast kit and tested for quality with both UV absorbance
and agarose gel electrophoresis.
Microarray hybridizations
Using the Genisphere Array 900 kit, we prepared cDNA
from mRNA for the two RNA populations and conducted
a two step hybridization involving Cy3 and Cy5 fluoro-
phores to a DNA microarray spotted with 70 mer oligos
that represent the known reading frames in the yeast
genome. Hybridized microarrays were then scanned using
the GCAT scanner at Davidson College to generate images
that could be subjected to microarray analysis. We used
the Cy3 and Cy5 dyes in opposite ways in replicate exper-
iments (so-called dye swapping). We gathered data suita-
ble for analysis from a total of five different microarray
experiments, with two of them conducted as dye swaps of
the other three. Moreover, each experiment included two
copies of the oligo set for all of the yeast open reading
frames.
Microarray data analysis
In order for the microarray data for a given gene to be
used, the sum of the intensities for the two channels had
to be greater than the minimum median of that sum for
all the experiments and the foreground for at least one
channel had to be double the background. In addition,
data passing these criteria had to come from at least 5 of
the 10 experiments and be represented in Cy3- and Cy5-
labelled samples. Finally, the coefficient of variation of
log2 transformed ratios across experiments had to be less
than one. The culmination of our analysis was a list of
ORFs for which we had reliable microarray data. We chose
to limit the list to those for which the effect of drug treat-
ment was two-fold or greater.
Real time PCR
Quantitative reverse transcription PCR was performed
using primer sets designed to amplify a region of about
100 bp near the 3' end of the mRNA. An ABI Prism 7000
followed the reactions run in 96 well plates using the
standard curve method. Three replicates were performed
for each concentration for the standard curve, and 4 repli-
cates for each gene. Reactions were set up using the ABI RT
kit and SYBR green reagent mixture. TUB1 served as the
internal standard gene [21]. After data were collected, the
samples were subjected to thermal denaturation to verify
that single species had been synthesized.
Sequence analysis
We assembled a list of 54 genes that were shown to be
affected by berenil treatment in our microarray experi-
ments. These were subdivided into 40 genes hypothesizedBMC Genomics 2008, 9:32 http://www.biomedcentral.com/1471-2164/9/32
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to be directly affected (Table 2) and 14 genes hypothe-
sized to be indirectly affected (Table 3). We also compiled
a list of 56 genes that were reliably unaffected by berenil
treatment. For each gene, we measured the occurrence of
5-mer and 6-mer sequences in the 200 nt region upstream
of the start site for translation, using the sense strand only
The percentage of affected genes that had an occurrence
for a sequence was compared to the percentage of control
sequences in which the sequence occurred. The 5-mers
whose percentage of affected genes was at least two stand-
ard deviations above the mean and the 6-mers whose per-
centage of affected genes was at least four standard
deviations above the mean were ranked according to the
difference between the percentage for affected and control
genes, and the top ten for the direct category are listed in
Table 4 while those for the indirect category are listed in
Table 6. The number of occurrences of 5-mers and 6-mers
was determined for the upstream 200 bp sequences of the
40 direct category genes, the 14 indirect category genes,
and the 56 unaffected control genes. The ratio of the
number of occurrences of affected versus unaffected was
calculated, correcting for the number of genes in each set.
The 5-mers whose occurrence was at least two standard
deviations above the mean and 6-mers whose occurrence
was at least four standard deviations above the mean were
ranked according to the ratio of occurrences in affected
genes to occurrences in unaffected genes. The top ten
sequences are listed in Table 5 for the direct category and
Table 7 for the indirect category.
Microarray Data Availability
All the microarray data generated for this report are avail-
able on the Genome Consortium for Active Teaching
(GCAT) website [32].
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